Elsevier

The Lancet

Volume 320, Issue 8292, 31 July 1982, Pages 231-234
The Lancet

SERUM AMYLOID-A PROTEIN CONCENTRATION IN INFLAMMATORY DISEASES AND ITS RELATIONSHIP TO THE INCIDENCE OF REACTIVE SYSTEMIC AMYLOIDOSIS

https://doi.org/10.1016/S0140-6736(82)90321-XGet rights and content

Abstract

Serum amyloid-A protein (SAA) is the putative precursor of amyloid-A (AA) protein which forms the fibrils in reactive systemic or secondary amyloidosis. By means of a novel immunoradiometric assay, the concentration of SAA was found to be greatly elevated in patients with rheumatoid arthritis and juvenile chronic arthritis and correlated with activity of their primary disease. However, in patients with systemic lupus erythematosus SAA levels were only modestly raised, even in those with severe active disease, unless significant intercurrent microbial infection was also present. In Crohn's disease SAA levels showed a pattern similar to that seen in rheumatoid arthritis, whereas in ulcerative colitis it resembled that of systemic lupus erythematosus. The level of SAA response in these different disorders corresponds with the incidence of reactive systemic amyloidosis in them. These observations support the view that major increases in SAA levels are a necessary condition for the deposition of this form of amyloid and suggest that prospective monitoring of the SAA concentration in predisposing diseases may help to identify those individuals who are most at risk for amyloidosis.

References (27)

  • Md Benson et al.

    Serum amyloid A protein in amyloidosis, rheumatic and neoplastic diseases

    Arthritis Rheum

    (1979)
  • Ma Schemberg et al.

    SAA amyloid protein levels in amyloid-prone chronic inflammatory disorders. Lack of association with amyloid disease

    J Rheumatol

    (1980)
  • Tj Schnitzer et al.

    Amyloidosis in juvenile chronic polyarthritis

    Arthritis Rheum

    (1977)
  • Cited by (175)

    • Hiding in Plain Sight: Cardiac Amyloidosis, an Emerging Epidemic

      2020, Canadian Journal of Cardiology
      Citation Excerpt :

      Although the underlying pathogenesis is unknown, the prevailing theory is that uncontrolled inflammation and the subsequent prolonged expression of circulating SAA is a critical prerequisite which encourages amyloid development.75 Because a prolonged inflammatory state does not dictate progression to amyloidosis—with AA amyloidosis occurring in only 5%-10% of persistent chronic inflammatory conditions76,77—it is a certainty that there are disease-modifying factors. In this regard, AA amyloidosis development is likely a consequence of underlying conditions and genetic polymorphisms.

    • Conventional markers in determination of activity of sarcoidosis

      2015, International Immunopharmacology
      Citation Excerpt :

      The similar results obtained by another study performed in Turkey also support this argument [23]. SAA is a marker of inflammation and its relation with sarcoidosis activity has recently drawn attention [24]. It has been shown that the SAA levels can increase, irrespective of sarcoidosis activity [25].

    • Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties

      2014, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Although persistently high concentrations of SAA proteins comprise a plausible risk factor for AA amyloidosis, a detailed molecular mechanism has not been elucidated. AA amyloidosis occurs in only 5–10% of humans during persistent chronic inflammatory conditions [2], indicating the existence of disease-modifying factors [3]. Instead of full-length SAA proteins (104 amino acids), the N-terminal fragments mainly consisting of 76-amino acid SAA molecules known as AA fragments have been detected in amyloid deposits [4].

    View all citing articles on Scopus
    View full text